Showing results (291-300 of 338) with videos related to
Sort By:
Pageof 34
Signal Transduction and Targeted Therapy|April 17, 2023
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinomaJunhui Hu, Ping Tan, Moe Ishihara, et al.Nature Communications|June 6, 2020
Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.The EMBO Journal|December 24, 2014
Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancerZhong Chen, Xun Lan, Jennifer M Thomas-Ahner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Targeting AXL Inhibits the Growth and Metastasis of Prostate Cancer in BoneChun-Lung Chiu, Dalin Zhang, Hongjuan Zhao, et al.The Journal of Experimental Medicine|October 29, 2024
IMPA1-derived inositol maintains stemness in castration-resistant prostate cancer via IMPDH2 activationChe-Chia Hsu, Guihua Wang, Chien-Feng Li, et al.Nature Biomedical Engineering|June 16, 2026
Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancerFurong Huang, Fuwen Yuan, Kexin Li, et al.Molecular Cancer Research : MCR|March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass HeterogeneityRahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.Clinical Chemistry and Laboratory Medicine|October 6, 2025
Estimated waste generation from 1 million basic metabolic panels: a multisite U.S. studySeema Khattri Bhandari, Kwaku Twum, Erving T Laryea, et al.Journal of the American Academy of Dermatology|September 5, 2022
Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 diseaseDaniel M O'Connor, Fadi Murad, Melissa J Danesh, et al.Nature Communications|December 4, 2019
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancerQiuhui Li, Bigang Liu, Hsueh-Ping Chao, et al.Pageof 34